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Background
Allergenic extracts from different companies or even
different batches of the same company can show great
variation in allergens content and relative potency (RP).
The objective of this study was to compare allergenic
extracts of mites produced with raw material from dif-
ferent suppliers.
Methods
Seven allergenic extracts produced with Dermatopha-
goides pteronyssinusfrom six suppliers were compared:
extract A (USA), B and C (Spain), D (Argentina),
E (Costa Rica), F and G (The Netherlands). This evalua-
tion was carried out comparing the dosages of groups 1
and 2 major allergens of Dermatophagoides (ELISA -
INDOOR Biotechnologies), RP (Competition ELISA -
FDA Allergenic) and protein bands pattern (SDS-PAGE)
among extracts.
Results
The content of groups 1 and 2 allergens ranged from 21
(B) to 49 µg/mL (A), and from 4 (D) to 50 µg/mL (F),
respectively. The RP varied from 0.25 (D) to 2.08 (F),
when compare with the FDA Allergenic IHR. The pro-
tein bands pattern were characteristic of mite D. ptero-
nyssinus, however, in F were observed some protein
bands which had not seen in others extracts, and in G
were observed only group 1 and 2 major allergens. The
results showed that there are significant differences
between extracts made with raw material from different
suppliers and even between extracts produced with raw
material from the same supplier (extracts F and G). The
results found in this study cannot be explained by
differences in the manufacturing process, since all
extracts were produced by the same process. The
extracts with the greatest quantities of major allergens
and relative potency (A and F) were produced with
semi-purified raw material (both with more than 99% of
purity), while the other extracts were produced with
mite whole culture (mites, feces and culture media).
Conclusions
It was concluded that the quality or purity of raw mate-
rial used in the manufacturing process of allergenic
extracts directly influences the final product quality, and
therefore, analytical methods to control the relative
potency, in order to assure batch to batch reproducibil-
ity, are essential to effectiveness and safety of allergenic
products.
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